Manipal Health Receives SEBI Approval for $1.2 Billion IPO

Manipal Health Enterprises, supported by Singapore's Temasek, has secured approval from SEBI to proceed with its Initial Public Offering (IPO), which is expected to launch in late July or early August. The hospital chain is targeting one of the largest healthcare IPOs in India, with plans to raise up to $1.2 billion, despite a challenging market environment marked by geopolitical tensions and sustained foreign investor outflows. According to sources familiar with the matter, Manipal Health has received the necessary regulatory clearance from the Securities and Exchange Board of India (SEBI) for its public listing. The proposed offering is anticipated to rank among the largest IPOs by an Indian healthcare company. The company had submitted its draft IPO papers in March, aiming to capitalize on the growing demand for advanced and specialized healthcare services. The planned listing comes at a time when escalating geopolitical uncertainties, including tensions arising from the Iran conflict, have triggered significant foreign portfolio investor (FPI) selling. These market headwinds have weighed on investor sentiment, prompting several companies to adopt a more cautious stance toward public offerings and contributing to a slowdown in IPO activity. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.